NEW YORK (
) hit a new 52-week high Monday as it traded at $76.88 compared with its previous 52-Week high of $76.87. Perrigo is changing hands at $76.88 with 172,352 shares traded as of 10:06 a.m. ET. Average volume has been 760,700 shares over the past 30 days.
Perrigo has a market cap of $6.7 billion and is part of the
industry. Shares are up 19.9% year to date as of the close of trading on Friday.
Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API), and medical diagnostic products worldwide. The company has a P/E ratio of 24.6, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 22.6.
TheStreet Ratings rates Perrigo as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and notable return on equity. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full
52-week high stocks
or get investment ideas from our